Zantac Lawsuits – Bladder, Kidney, Pancreatic, Colon & Stomach Cancer
Charlip Law Group, LC has filed lawsuits on behalf of clients who took Zantac and have been diagnosed with bladder, kidney, pancreatic, colon or stomach cancer. Our firm will be reviewing other potential client intakes involving clients who contracted cancer after taking Zantac.
Zantac Lawsuits – Factual Background
Zantac is the brand name for Ranitidine. Zantac and Ranitidine are used to treat certain stomach and throat problems such as erosive esophagitis, gastroesophageal reflux disease “GERD”, and Zollinger-Ellison syndrome. Zantac is also used to treat ulcers of the stomach and intestines and prevent them from coming back after they have healed. Zantac works by decreasing the amount of acid created by the stomach. Zantac relieves symptoms such as persistent coughs, stomach pain, heartburn, and difficulty swallowing. Zantac and Ranitidine belong to a class of drugs known as H2 receptor blockers.
Valisure, LLC is an online pharmacy currently licensed in 38 states and an analytical laboratory that is ISO 17025 accredited by the International Organization for Standardization (“ISO”). Valisure is registered with the Drug Enforcement Administration (Pharmacy: FV743 l 137, Laboratory: RV0484814) and the FDA (FEI #: 3012063246). Valisure’s mission is to help ensure the safety, quality and consistency of medications and supplements in the market. In response to rising concerns about counterfeit medications, generics, and overseas manufacturing, Valisure developed proprietary analytical technologies that it uses in addition to FDA standard assays to test every batch of every medication it dispenses.
Valisure discovered the link between ranitidine and NDMA formation during its routine analysis of drug products in its pharmacy. Valisure found incredibly high levels of NDMA in every lot of Ranitidine it tested. For example, Valisure found 2,511,469 ng of NDMA in Zantac, Brand OTC, and 3,267,968 ng of NDMA in Zantac (mint), CVS. Again, the FDA daily limit is 96 ng. During the period in which Ranitidine products, including Zantac, have been sold in the United States, hundreds of reports of injuries, including but not limited to various cancers have been submitted to the FDA in association with ingestion of Ranitidine and Zantac.
The first Zantac lawsuit was filed in California the day the FDA issued its advisory. Plaintiffs accuse drugmakers Sanofi and Boerhringer Ingelheim of manufacturing, marketing, and selling a product they knew or should have known had been contaminated with an industrial chemical known to cause cancer.
On September 13, 2019 the Food and Drug Administration issued a warning that the heartburn medicine Zantac (generic ranitidine) contains the cancer-causing chemical NDMA.
Zantac and its generic versions have been pulled from shelves of Walmart, Rite Aid, CVS and Walgreens stores after the FDA announced that it had detected the cancer-causing chemical in samples of the drug.
Potential carcinogenic effects of NDMA exposure include:
- Stomach cancer
- Bladder cancer
- Kidney cancer
- Pancreatic cancer
- Colon cancer
Charlip Law Group, LC is investigating Zantac-related cancer and potential harm that may have come from taking Zantac. A Zantac cancer lawsuit may help victims recover damages for:
- Medical costs
- Lost wages
- Pain and suffering
- Disability or permanent injury
- Punitive damages
- Wrongful death
People or loved ones of those who developed or were diagnosed with cancer after taking Zantac may be eligible for compensation and should seek advice from a board-certified civil trial lawyer with over 35 years of pharmaceutical products liability experience such as David H. Charlip, B.C.S of Charlip Law Group, LC.
Contact Charlip Law Group, LC. for a free case evaluation, or call at 1(888) 815-1418 or (305) 354-9313.